INBP
What one share of Integrated Biopharma holds
Pharmaceutical Preparations
Integrated Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.41 |
|---|---|
| Profit | −$0.09 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | $0.03 |
| Cash and investments | $0.14 |
| Book value | $0.57 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $1.56 | $0.10 | $0.01 | $0.00 | — | −$0.28 |
| 2018 | $1.44 | $0.02 | $0.01 | $0.03 | — | −$0.25 |
| 2019 | $1.69 | $0.06 | $0.01 | −$0.00 | — | $0.06 |
| 2020 | $1.69 | $0.13 | $0.01 | $0.04 | — | $0.20 |
| 2021 | $1.98 | $0.25 | $0.01 | $0.09 | — | $0.48 |
| 2022 | $1.74 | $0.12 | $0.01 | $0.11 | — | $0.62 |
| 2023 | $1.69 | −$0.00 | $0.00 | $0.04 | — | $0.63 |
| 2024 | $1.63 | $0.00 | $0.02 | $0.01 | — | $0.64 |
| 2025 | $1.74 | $0.03 | $0.01 | $0.06 | — | $0.65 |
| 2026 | $1.41 | −$0.09 | $0.01 | $0.03 | — | $0.57 |